CANCER IS A METABOLIC DISEASE
REAL-WORLD EVIDENCE PROVIDES REAL-WORLD VALUES GATHERED FROM ACTUAL PATIENT MEDICAL RECORD.
Compiling observations and administration of Golden Sunrise Nutraceutical products should always be under the supervision of a licensed physicians, registered nurse, and medical specialists in the medical field. Recommendations for Golden Sunrise Nutraceutical products are based on the following criteria; Medical evaluation, assessment, diagnoses, monitoring, and medical report results of the patient. Evidence-Based Care is a set of principles and methods intended to ensure that to the greatest extent possible thru best clinical judgments or medical decisions are made.
CANCER CASE REPORTS
1.1. Patient with Pancreatic Cancer.
G.T. is a 71-year-old Hispanic male was that diagnosed with stage four pancreatic cancer on May 03, 2025, Cancer Antigen 19-9 (CA 19-9) levels were recorded at 162-Ul/mL, Carcinoembryonic Antigen (CEA) levels were recorded at 1.7-ng/mL, and found the pancreatic cancer has spread throughout his body. Patient blood report results on April 29, 2025 through April 30, 2025, Glucose levels were recorded at 210-mg/dL, Creatinine levels were recorded at 0.75-mg/dL, Bilirubin levels were recorded at 4.7-mg/dL, Alkaline Phosphatase levels were recorded at 1050-IU/L, AST levels were recorded at159-IUL, ALT levels ere recorded at 155-IU/L. Patient complained of lower back pain, increasingly constipated, fatigued, and depressed at the diagnosis. Patient had been going to California Los Angeles Hospital (Hospital) and was being prepared fro chemotherapy treatment. Patient did not want to take chemotherapy treatment as he witnessed his friends and family receive chemotherapy treatments without successful outcomes. Patient heard of Golden Sunrise Nutraceutical Cancer Treatment (Cancer Treatment) through his family and set up an appointment with Mrs. Fontana at Oakview Medical Group. Patient agreed to try Cancer Treatment and him and his family left chemotherapy treatment on the table if Cancer Treatment was unsuccessful. Mrs. Fontana discussed his option and prescribed Cancer Treatment for him on May 17, 2025. Results: Patient was prescribed Cancer Treatment, shortly after patient was taking Cancer Treatment he could have a Bowel Movement (BM) and after this he steadily improved his BM's to 3-times per day. After a month patient energy levels noticeably health improved where he could walk outside and water plants. Patient depression no longer was an issue, his back pain which he claimed he suffered from for many years no longer was an issue, recovery continued health improve, mental clarity, and none of the previous issues were of note by this time. After Cancer Treatment there was taken a complete blood report results on May 03, 2025 through May 08, 2025, and found that patient Glucose levels had decreased from 210-mg/dL to 188-mg/dL, Creatinine levels had decreased from 0.75-mg/dL to 0.56-mg/dL, Bilirubin levels had decreased from 4.7-mg/dL to 1.3-mg/dL, ALkaline Phosphatase levels had decreased from 1050-IU/L to 475-IU/L, AST levels had decreased from 150-IU/L to 47-IU/L, and ALT levels had decreased from 155-IU/L to 58-IU/L. Patient after four weeks was prescribed by Mrs. Fontana of Cancer Treatment. On May 08, 2025 patient then went back to the Hospital to update for the blood report results and discuss options for chemotherapy treatment. The oncologist at Hospital said to hold off on the chemotherapy treatment and then patient panning to go on vacation. Patient family planed for him to go to Mexico and enjoy a relaxing time. Before Cancer Treatment his family expected patient to be bedridden due to the debilitating effects of the cancer or disease. After Cancer Treatment patient family says they see his health conditions improving every day since Cancer Treatment was begun, he has more energy to work in his garden. On May 03, 2025 through May 23, 2025 CEA levels had increased from 1.7-ng/mL to 2.0-ng/mL and CA 19-9 levels had increased from 162-U/mL to 246-U/mL. On June 28, 2025 patient son said that his father cough had been reduced and patient was walking more. Patient son said previous day he walked 12,000-steps. On July 15, 2025 through July 21, 2025 Glucose levels had decreased from 253-mg/dL to 211-mg/dL, Creatinine in normal range from 0.80-mg/dL to 1.30-mg/dL, Alkaline Phosphatase in normal range from 98-IU/L to 96-IU/L, AST in normal range from 28-IU/L to 30-IU/L, and ALT in normal range from 23-IU/L to 25-IU/L. Magnetic Resonance Imaging (MRI) MR Abdomen W/WO Contrast on May 01, 2025 through July 21, 2025 Pancreas; Mildly improved pancreatic ductal dilatation in the body and tail levels had decreased from 8-mm to 5-mm. MRI On July 21, 2025 Biliary; Mildly improved intrahepatic bile duct dilatation in the left lobe, Pancreas; Heterogeneous Hypoenhancement level at a 1.4-cm, Pancreas; restricted diffusion area level at a 2.7-cm, Liver; No significant abnormality. Mildly enlarged level at a 19-cm, Spleen; No significant abnormality. Borderline enlarged level at a 12-cm, Kidneys; No significant abnormality. Simple bilateral renal level at a 3.1-cm, Retroperitoeum; Multiple porta hepatis and peripancreatic lymph nodes are seven, with a peripancreatic lymph node level at a 1.2-cm, Retropeitoeum; Portacaval lymph node short axis level at a 1.1-cm, Adreanals; No visible adrenal lesion, Aorta and Vasculature; No significant atherosclerosis. Re-demonstration of narrowed portal splenic confluence and splenic vein, Bowel; No significant abnormality. Re-demonstration of duodenal diverticulum, Mesentery/peritoneum; No mass or ascites, Abdominal Wall; No significant abnormality, Bones; No significant abnormality, and Lung Bases; Bilateral lung base patchy nodular hyperintense signals. Lung bases not well assessed with MRI. MRI MR Pelvis Male W/WO Contrast on July 21, 2025 Aorta/Iliac; No significant arterial abnormality for patient's age on limited evaluation, Bowel; No significant abnormality on limited evaluation, Mesentery/Peritoneum; No significant abnormality on limited evaluation, Abdominal Wall; No significant abnormality on limited evaluation, Bladder; No significant wall thickening or calculus, Pelvic Nodes; Bilateral obturator and external iliac chain lymph nodes level at a 0.9-cm in short axis on the right. These are nonspecific and may be reactive, Pelvic Organs; No visible mass, Bone; L4-L5 degenerative disc disease. No suspicious bony lesion identified, and Other; Bilateral inguinal lymph nodes level at a 1.0-cm in short axis.
* FINDINGS: Mildly improved pancreatic ductal dilatation in the body and tail, measuring up to 5-mm, previously 8-mm. No significant peripancreatic inflammation/pancreatitis is appreciated on current study. This finding indicates that the pancreatic duct in the body and tail of the pancreas was previously dilated to 8-mm and has since reduced in size to 5-mm.
1.2. Patient with Prostate Cancer.
C.S. is an 83-year-old white male that was diagnosed with prostate cancer on October 10, 2024. Prostate-Specific Antigen (PSA) levels were recorded at 13-ng/ml and he complained of an increase feeling of being tired all the time and had no energy function in day-to-day tasks. After patient diagnosis he was asked to take chemotherapy treatment by his initial physician but refused. Patient was looking for alternative therapies and wished to use herbal, botanical, or nutritional alternatives. Patient heard Golden Sunrise Nutraceutical Cancer Treatment (Cancer Treatment) and consented to take Cancer Treatment. Patient had said if Cancer Treatment would prolong his life and give himself good for three years quality-of-life, feeling well, and he would be happy with it. The Cancer Treatment was administered by Oakview Medical Group under the supervision of Sonja I FONTANA (Mrs. Fontana), CPC-FNP-C. Results: On November 05, 2024 patient was tested again and his PSA levels had decrease from 13-ng/mL to 9.6-ng/mL. Patient again said he had more energy to do whatever he wanted and was very happy with the results from Cancer Treatment and he will continue the Cancer Treatment. Patient went to his oncologist for an update as to his prostate cancer on May 10, 2025. The oncology doctor had been pushing him to get chemotherapy treatment. When the patient talked with the oncologist, doctor said no action was needed as his prostate cancer was not progressing. The oncologist had received blood report results that showed patient improvement and did not want to move forward with any chemotherapy treatment and said to keep doing what you are doing.
1.3. Patient with Colon Cancer.
J.O. is a 45-year-old white male was that diagnosed with advanced stage four colon cancer on January; 2016. After the initial consultation Golden Sunrise Nutraceutical Cancer Treatment (Cancer Treatment) patient didn't want Cancer Treatment and began chemotherapy treatment. Patient received the first cycle of chemotherapy treatment on March; 2016. Patient symptoms included a damaged liver, renal obstruction, lung polyps, anxiety, depression, and severe lack of energy. After patient first round of chemotherapy treatment he came back and wanted Cancer Treatment of both chemotherapy treatment and Cancer Treatment. Patient received twenty-two rounds of chemotherapy treatment while taking Cancer Treatment. Results: in April; 2016 patient received his first dose of Cancer Treatment administered orally and patient showed noticeable improvement in overall health in minutes. Patient didn't lose his hair, constipation was reduce, he showed an improvement in energy levels as the next day he was playing basketball, mental focus, depression, anxiety improved noticeably, and his outlook on life was a positive hope. Patient's blood report results revealed that the White Blood Count (WBC) levels had increased from 5.70-10^3/uL to 6.70-10^3/uL and Platelet count levels had increased from 70-10^3/uL to 78-10^3/uL on April; 2017 through May; 2017. WBC levels had increased from 5.70-10^3/uL to 7.70-10^3/uL and Platelet count levels had increased from 70-10^3/uL to 187-10^3/uL on April; 2017 through November; 2017. Patient tumors have shrunk and since Cancer Treatment and chemotherapy treatment he has had no major side-effects such as hair loss, debilitating constipation, depression, anxiety, weight loss, or nausea. Patient has not had to visit the emergency for complications except for a staph infection. Patient is doing well and can function without interference with his normal lifestyle. Patient has been motivated to tell other cancer patients of the benefits of taking Cancer Treatment that it can help other patients with serious or Life-threatening illnesses.
1.4. Patient with Esophageal Cancer.
R.H. is a 54-year-old white male that was diagnosed with esophageal cancer on December 26, 2016. Patient was rushed to the local emergency room where testing immediately began and the diagnosis was made. Patient's esophageal cancer progression was identified in stage two after patient collapsed for no apparent reason and began spewing blood. Patient refused standard medical chemotherapy treatment at Houston Texas Hospital (Hospital). Patient had pain in patient's knees for 20-years from playing professional Football, patient claimed that to sleep he would have to "Ice" on his knees to deal with the pain. Results: Patient began taking Golden Sunrise Nutraceutical Cancer Treatment (Cancer Treatment) on February 20, 2017 and showed improvements in blood report results; White Blood Count (WBC) levels had increased from 6.4-10^3/uL to 9.4-10^3/uL, Mean Platelet Volume levels had increased from 6.9-fL to 8.4-fL, and Platelet count levels had decreased from 375-10^3/uL to 332-10^3/uL on March 14, 2017. On March 21, 2017 patient had biopsies that were conducted and esophageal mucosal changes were noticed that was consistent with Barrett's esophagus. The physician at Hospital after reviewing both the blood report results and medical scan results recommended; "Resume regular diet" and "received another checkup in four weeks". Patient was referred back to primary care physician. No chemotherapy treatment was prescribed. Patient was observed with improved energy and reduction in pain, but after one month of Cancer Treatment the patient noticed the pain was gone and did not need to "Ice' on his knees anymore.
1.5. Patient with Lymphocytic Leukemia.
M.B. is a 69-year-old white male that was diagnosed with chronic Lymphocytic Leukemia on August 17, 2010. Patient started taking Golden Sunrise Nutraceutical Cancer Treatment (Cancer Treatment) on October; 2015. This was because of the concern about falling Red Blood Count (RBC) and Platelet count. Patient White Blood Count (WBC), though elevated remained elevated, and fluctuant. Results: On October; 2015 through April; 2016, patient RBC levels had increased from 4.05-10^3/uL to 4.19-10^3/uL and Platelet count levels had increased from 90-10^3/uL to 105-10^3/uL. It was that this was significant increase in both patient RBC and Platelet count.
1.6. Patient with Liver Cancer.
T.B. is a 72-year-old white male that was diagnosed with stage four liver cancer on July; 2006. Patient complained of excruciating pain and could not find relief from any source of medication or alternative treatment. Results: Patient began taking Golden Sunrise Nutraceutical Cancer Treatment (Cancer Treatment) and in matter of days the pain had subsided. On December; 2007 through February; 2008, patient Alkaline Phosphatase levels had decreased from 163-IU/L to 120-IU/L, AST levels had decreased from 46-IU/L to 31-IU/L, and ALT levels had decreased from 68-IU/L to 35-IU/L.
1.7. Patient with Brain Tumor.
V.A. is a 7-year-old Hispanic male that was diagnosed Central Neurocytoma Gadolinium (Brain Tumor) on April 04, 2007 with a left intraventricular tumor and obstructive hydrocephalus. Patient had received nine cycles of chemotherapy treatment, radiation, and surgery at Fresno California Hospital. The chemotherapy treatment, radiation, and surgery left the patient weak and unable to get out and play, he couldn't sleep and had seizures up to about ten times daily. Patient didn't believe he had a chance to live because the oncologist said that patient had an infection in his brain which was of grave concern and gave no hope for the patient to survive (the doctors had told patient no patient survives more than eleven months with a brain tumor, then the patient's aunt heard of Golden Sunrise Nutraceutical Cancer Treatment (Cancer Treatment) and that this could help her nephew. Mother of the patient called Golden Sunrise Nutraceutical (Golden Sunrise) to help her son and Golden Sunrise medical staff came to there house and treated the patient with Cancer Treatment on January 05, 2008. Results: Patient received the Cancer Treatment about and in 10-minutes, the patient started feeling nauseous, and started sweating then after 20-minutes he started vomiting for a few minutes after the patient finished vomiting he asked for water he drank six glasses of water back to back then the patient put his hand on his heart and said I'm happy here then he patted his hand on his head and said I'm happy here with alertness, then patient ran out the door, and started to play. The patient ran around the front yard and played for at least an hour. On August 14, 2008 Magnetic Resonance Imaging (MRI) scan report Findings: There is no convincing evidence for leptomeningeal enhancement on post-contrast sagittal T1-weighted images. Impression: No convincing evidence for residual or recurrent tumor. On March 05, 2009 MRI Cervical, Thoracic, Lumber scan report Findings: There is no convincing evidence for leptomeningeal tumor in the cal sac or on the surface of the spinal cord. Some faint dark signal at the tip of the cal sac is again noted but this is not pathognomic of tumor. No overt enhancement of the tip of the cal sac is noted. Impression: No convincing evidence for recurrent tumor. On March 05, 2009 MRI Brain WITH 70553 scan report Findings: No mass lesions are noted in the frontal horns of either lateral ventricle and no abnormal leptomeningeal enhancement is noted elsewhere. The ventricles are slightly prominent but stable compared with the last study. The visualized vascular structures are within normal limits. Artifact from the shunt system in the right transverse sinus region is noted. Impression: Post-therapy changes including leukoencephalopathy in the frontal lobes bilaterally, and in both cerebellar hemispheres. There is no convincing evidence for recurrent, residual, or metastatic. On June 04, 2009 MRI Brain WITH 70553 scan report Findings: The non-enhancing deep white matter hyperintensities within both cerebral hemispheres are stable. Non-enhancing hyperintensities within the central portions of both cerebellar hemispheres are also stable. These changes may be related to the effect of prior therapy. There is no evidence of restricted diffusion. Impression: There are no changes to suggest progressive infection. Diffuse dural thickening and enhancement is stable. Patient had completed high school and wants to go to college.
1.8. Patient with Breast Cancer.
J.P. is a 44-year-old white female that was diagnosed with stage I breast cancer on December; 2018 and was found with a lump. The patient had refused Chemotherapy treatment, radiotherapy, and surgery and only interested in trying alternative approaches to treating her cancer. The patient had heard of Golden Sunrise Nutraceutical (Golden Sunrise) and contacted the medical director. The patient was medically evaluated and Golden Sunrise Cancer Treatment (Cancer Treatment) was begun in February 10, 2019. Results: The patient received Cancer Treatment for approximately 5-months until was found that the patient was in remission. On July 31, 2019 the lymph node ultrasound results are clear and cryoablation went well on July 31, 2019. Insurance company evaluated the Cancer Treatment and medical report results that actual treatments and then proceeded to cover the costs of the Cancer Treatment.
DIABETES CASE REPORT
1.9. Patient with Type 1 Diabetes.
N.O. is a 20-year-old white male that was diagnosed with Type 1 Diabetes on February; 2011. Patient requires lifelong insulin injections daily to manage his blood glucose levels. Patient's diet is restrictive though the patient rarely follows his diet regiment. Patient started with Golden Sunrise Nutraceutical Metabolic Treatment (Metabolic Treatment) on May 10, 2019. Results: After the patient was administered the Metabolic Treatment, the patient was then monitored by medical staff for a response. After a short period of time the patient's blood glucose levels showed a significant decrease from 440-mg/dL to 60-mg/dL in less than two hours without the patient experiencing any symptoms such as dizziness, weakness, sweating, the patient did not demonstrate any adverse-effects, etc., and still carry on the usual daily activities.
MULTIPLE SCLEROSIS CASE REPORT
1.10. Patient with Multiple Sclerosis (MS).
E.B. is a 46-year-old white male that was diagnosed with Multiple Sclerosis (MS) in June; 2003. Patient was first suspected as having lime disease but upon further testing it was found to be MS, patient experienced almost total immobility of legs, arms. What mobility there was, showed extreme spasmodic function, and continual degradation of motor function until he was bedridden. Patient blood report results on September 06, 2017 showed a White Blood Count (WBC) levels were recorded at 6.04-Thousand/UL and Platelet count levels were recorded at 206-Thousand/UL. Patient was debilitated from the beginning and wasn't responding to prescription drugs, so patient did three rounds of chemotherapy treatment to stop the progression. Patient was able regain quite a bit of his function, but experienced significant pain. Patient was in a significant amount of pain despite being on multiple heavy pain medications. On November 01, 2016 patient ended up in the Hospital for twenty-four hours, due to complications of his MS. When the patient came home from the Hospital he was now bed bound and completely dependent. Results: Patient began taking Golden Sunrise Nutraceutical Metabolic Treatment (Metabolic Treatment) on October 04, 2017. A positive response to a first dose of Metabolic Treatment is generally a good sign, indicating the Metabolic Treatment is having effectiveness this refers to Real-World Evidence. Over the course of Metabolic Treatment the patient has experienced improved motor function to where he can sit in a wheelchair, move himself and can sit on the toilet without the aid of the caregiver. Patient continues to show marked improvement as the Metabolic Treatment progresses, the WBC results and Platelet count results show improvement supporting the physical observations. On December 06, 2017 WBC levels had increased from 6.04-Thousand/UL to 9.60-Thousand/UL and Platelet count levels had increased from 206-Thousand/UL to 254-Thousand/UL. In December; 2018 patient is off all his pain medications and patient is no longer on his MS medications including high doses of eight plus medications. Within a year the patient taking Metabolic Treatment has cognitive function returned, he can talk, and eat again. Patient's limbs function are return in after Metabolic Treatment and now with physical therapy he has been able to walk assisted small distances, Patient is able to stand for a short time, and quality-of-life has significantly improved. Patient previous prescription drug costs for Medicare were around ninety-six thousand ($96,000.00) dollars per year. On February; 2019 patient prescription drug costs are reduced around two thousand ($2,000.00) dollars per year.
SEIZURES DISORDER CASE REPORTS
1.11. Patient with Seizures Disorder.
A.V. is an 8-year-old Hispanic male with severe global development delays, seizures, a history of recurrent rhabdomyolysis, status post resection of a left temporal epidermoid cyst, brain biopsy, and the patient began to develop seizures around the age of 3-year-old. Mom states that during the seizures, the eyes, eyelids dropped down, and that has seizures 30-times per day. Patient started taking Golden Sunrise Nutraceutical Metabolic Treatment (Metabolic Treatment) on June 23, 2008. Results: After Metabolic Treatment, Outpatient Consultation on September 12, 2008 through September 24, 2008 the patient mom reports to the doctor that her son's seizures have been doing much better with only about two seizures per week and none of them particularly severe. The seizures are primarily drop seizures. They are brief. They are not tonic-clonic in nature. Patient is being managed currently on no seizure medications. The Metabolic Treatment is effective in reducing the frequency of his seizures.
1.12. Patient with Seizure Disorder.
K.A. is an 8-year-old Hispanic female that was diagnosed with symptoms of recurrent episodes suggestive of seizures on May 21, 2012, with repetitive eye blinking, brief zoning out, starting change in speech, and after this patient resumes ongoing activity. Patient was physician referred to Golden Sunrise Nutraceutical (Golden Sunrise) after the physician could not improve patient condition. Patient started taking Golden Sunrise Metabolic Treatment (Metabolic Treatment) on September 17, 2012. Results: After Metabolic Treatment, the patient noticed improved mental clarity and improved focus. Later, her teacher observed a dramatically improved focus and mental clarity. The seizure from RECURRENT EPISODES decreased to become a dramatically IMPROVED FOCUS and MENTAL CLARITY. Patient is being managed currently on no seizure prescription drugs.
LYME DISEASE CASE REPORT
1.13. Patient with Lyme Disease.
L.G. is a 51-year-old white female that was diagnosed with late-stage Lyme disease on August 10, 2010 Immunoglobulin G (IgG) test results; POSITIVE and on October 21, 2010 Immunoglobulin M (IgM) test results; POSITIVE. Patient symptoms; Daily headaches, frequent migraines, weight gain, brain fog, depression, anxiety, moderate to severe fatigue, moderate chronic pain, intermittent tremors, and memory loss. Patient undergoing various prescription drugs for over six years with eighteen different medications and IV antibiotics twice a day for a year, patient was told her specialist physicians they could offer no more hope. It was then an Registered Nurse (RN) who had seen great results from Golden Sunrise Nutraceutical Metabolic Treatment (Metabolic Treatment) from her patients suffering from other ailments and conditions or diseases, including cancer the RN suggested patient try Metabolic Treatment. Patient set up an appointment with Mrs. Fontana at Oakview Medical Group, she agreed to try the Metabolic Treatment, and patient started taking Metabolic Treatment on October 31, 2018. Results: After Metabolic Treatment, the patient went from barely functioning and being bedridden to working back toward a meaningful, productive life, and felt well. On August 10, 2010 through September 25, 2019 IgG blood serum from a POSITIVE result to become a NEGATIVE result and IgM blood serum from a POSITIVE result to become a NEGATIVE result. Patient was treated with Metabolic Treatment and the patient has recovered. Patient symptoms are being managed without prescription drugs.
HEPATITIS C CASE REPORTS
1.14. Patient with Hepatitis C.
H.J. is a 59-year-old white female that was diagnosed with chronic Hepatitis C virus on May; 1990. The patient was constantly being admitted to the Emergency for Life-threatening situations. Patient started taking Golden Sunrise Nutraceutical Metabolic Treatment (Metabolic Treatment) on November 22, 2010. Blood test for HCV RNA quantification using PCR measures the amount of Hepatitis C viral load levels were recorded at 28,800,000-IU/mL and 7.46-log IU/mL on January 19, 2011. Results: Patient was administered the Metabolic Treatment and immediately demonstrated a pronounced positive response alertness. The patient noticed an increase in the blood flow throughout her the body, an increase in energy, mental clarity, skin pigmentation, she had a feeling of well-being, and a release of anxiety. After Metabolic Treatment, patient rarely going to emergency room. On January 19, 2011 through March 08, 2012 HCV RNA quantification using PCR measures the amount of Hepatitis C viral load levels had decreased from 28,800,000-IU/mL to 3,485,375-IU/mL and HCV-RNA levels had decreased from 7.46-log IU/mL to 6.54-log IU/mL. On January 10, 2013 through February 22, 2015 AST levels had decreased from 57-IU/L to 27-IU/L, ALT levels had decreased from 52-IU/L to 23-IU/L, HCV RNA quantification using PCR measures the amount of Hepatitis C viral load levels had decreased from 69,000,000-IU/mL to 12,898,000-IU/mL, and HCV-RNA levels had increased from 7.10-log IU/mL to 7.11-log IU/mL. On March 08, 2013 through July 15, 2013 White Blood Count (WBC) levels had increased from 4.2-Thousand/UL to 5.1-Thousand/UL.
1.15. Patient with Stage III Chronic Kidney Disease and Hepatitis C.
C.R. is a 65-year-old white female that was diagnosed with stage III chronic kidney renal disease and Hepatitis C virus. The patient had a liver transplant in Year-2007. Patient started taking Golden Sunrise Nutraceutical Metabolic Treatment (Metabolic Treatment) on October 04, 2013. Results: The patient was administered the Metabolic Treatment and within 2-minutes there was a feeling of warmth throughout the body. Patient noticed an increase in energy levels in about 5-minutes and anxiety that the patient experienced was alleviated. On September 23, 2013 through October 21, 2013 Tacrolimus Highly Sensitive LC/MS/MS levels had increased from 1.4-mcg/L to 2.0-mcg/L, Platelet count levels had increased from 121-10^3/uL to 132-10^3/uL, and Gamma-Glutamyl Transferase levels had decreased from 1153-TU/L to 1109-TU/L, Alkaline Phosphatase levels decreased from 596-IU/L to 571-IU/L.
1.16. Patient with Chronic Cirrhosis Complication from Hepatitis C.
R.S. is a 54-year-old white male that was diagnosed with chronic cirrhosis complication from Hepatitis C. The patient condition is suffering chronic liver cirrhosis due to Hepatitis C infection that the patient contracted in the U.S. Hospital. Patient started taking Golden Sunrise Nutraceutical Metabolic Treatment (Metabolic Treatment) on August 14, 2010. Results: The patient was administered the Metabolic Treatment and immediately had a dramatic response, he could feel increased energy, an increased in blood flow through the body, a feeling of well-being, and mental clarity. On August 09, 2010 through August 31, 2010 White Blood Count (WBC) levels had increased from 4.2-K/cmm to 6.8-K/cmm and Platelet count levels had increased from 61-K/cmm to 92-K/cmm. Patient stated "Since taking the product, my quality of life has improved immensely, my energy levels are up, and my physical and emotional outlook have swung back to the optimistic. I now feel like I will be around to get a new liver and have many good years ahead."
STROKE CASE REPORT
1.17. Patient with a right Carotid Artery Dissection Resulting in Stroke.
S.M. is a 41-year-old white male that was diagnosed with a right carotid artery dissection which resulted in a stroke on June 29, 2010. He was suffering from complications to brain surgery. Part of the patient is skull had been removed, etc. Patient had experienced hiccups and headaches over 7-months and he was living with headaches daily, and loss of function to his left arm. Patient started taking Golden Sunrise Nutraceutical Metabolic Treatment (Metabolic Treatment) on January 20, 2011. Results: The patient was administered Metabolic Treatment and immediately noticed hiccups stopped, his headaches disappeared for 7-months period with reduced chronic pain, and recovery of arm function was returning. On January 11, 2011 through January 31, 2011 Prothrombin Time levels had decreased from 24.95-seconds to 21.95-seconds and International Normalized Ratio levels had decreased from 3.60-seconds to 2.90-seconds. Patient stated "I can function in society and not just lock myself in a room with the lights off all day long. I am no longer taking Oxycontin for my pain. What I call, a life saver for me." On May 09, 2011 through July 18, 2011 Prothrombin Time levels had decreased from 21.65-seconds to 10.80-seconds which is in the normal range taking the Metabolic Treatment and International Normalized Ratio levels had decreased from 2.69-seconds to 0.88-seconds which is in the normal range taking the Metabolic Treatment.
THALASSEMIA MAJOR CASE REPORT
1.18. Patient with Thalassemia Major and Iron Overload.
J.C. is a 19-year-old Asian male that was diagnosed with thalassemia major, assess cardiac function, cardiac iron, and hepatic iron in the Year-2008. Patient was suffering from Serious or Life-threatening conditions that physicians cannot provide appropriate treatment, the patient was receiving a transfusion every 2-weeks. On January 19, 2011 the White Blood Count (WBC) levels were recorded at 23.94-K/uL, Red Blood Count (RBC) levels were recorded at 3.37-M/uL, Hemoglobin (HGB) levels were recorded at 9.7-g/dL, Hematocrit (HCT) levels were recorded at 29.7%, Platelet count levels were recorded at 847-K/uL, AST levels were recorded at 107-IU/L, ALT levels were recorded at 136-IU/L, and Alkaline Phosphatase levels were recorded at 139-IU/L. Patient started taking Golden Sunrise Nutraceutical Metabolic Treatment (Metabolic Treatment) on January 31, 2011. Results: The patient was administered the Metabolic Treatment and has demonstrated an improved energy level and started playing with his younger brother. The patient has improved skin and can function in normal conditions whereas, on January 31, 2011 through August 29, 2011 WBC levels had decreased from 26.94-K/uL to 15.18-K/uL, RBC levels had increased from 3.36-M/uL to 3.57-M/uL, HGB levels had increased from 9.8-g/dL to 10.2-g/dL, HCT levels had increased from 29.7% to 31.1%, Platelet count levels had decreased from 738-K/uL to 596-K/uL, AST levels had decreased from 80-IU/L to 66-IU/L, ALT levels had increased from 91-IU/L to 92-IU/L, and Alkaline Phosphatase levels from 105-IU/L to 102-IU/L. The patient transfusion frequency have been reduced from every 2-weeks to every 3-weeks following the start of Metabolic Treatment.
MENOPAUSE CASE REPORT
1.19. Patient with Postmenopausal Synptoms, Migraines, Gastroesophageal Reflux Disease (GERD), Osteoporosis, Thumb Arthritis, Generalized Back Pain, and Neck Pain.
S.T. is a 59-year-old white female that was diagnosed with menopause, migraines, asthma like symptom from GERD, osteoporosis, large tissues in the sinus cavity that affect nasal breathing, left thumb arthritis, skin atrophy, sleep disorders, vision changes from day to day, generalized back pain, and neck pain on May 03, 2013. Patient was suffering from Serious or Life-threatening conditions that physicians cannot provide appropriate treatment and treatment options are limited. On July 05, 2017, patient age is 58-year-old the Densitometry of L1-L4; Bone Mineral Density (BMD) levels were recorded at 0.857-g/cm2, Change vs Baseline levels were recorded at -6.2%, and Change vs Previous levels were recorded at -3.6%. Patient started taking Golden Sunrise Nutraceutical Metabolic Treatment (Metabolic Treatment) on July 18, 2017. Results: The patient was administered the Metabolic Treatment and has overall dramatice dramatic results for pain, has an effect on patient nail and skin, slight to moderate improvement in thumb arthritis, GERD symptoms, neck migraines, migraines, foot pain, and hip pain is reduced. On July 05, 2017 through June 26, 2018, patient is 59-year-old the Densitometry of L1-L4 BMD levels had increased from 0.857-g/cm2 to 0.886-g/cm2, Change vs Baseline levels had decreased from -6.2% to -3.1%, and Change vs Previous levels had changed in 1-year from -3.6% to a 3.4% change in L1-L4 bone density compared to previous measurement is generally considered within the normal range. Patient had a steady energy supply, did not feel hunger as much, and she has been sleeping more.
BONE GROWTH THICKNESS CASE REPORT
1.20. Patient with a Dental Implants and Oral Surgery.
H.T. is a 58-year-old Asian male that required 2-replacement teeth with dental implants and Oral Surgery on February; 2020. Patient started taking Golden Sunrise Nutraceutical Metabolic Treatment (Metabolic Treatment) to help with blood loss and help bone growth on January; 2020. Results: When the dentist removed the patient teeth there was minimal blood loss and no pain medicine required during the procedure and during recovery. The healing process after teeth were removed was very fast with the dentist saying that the healing was that of a 20-year-old man not a 58-year-old man. When the dentist was ready to put new replacement teeth in he was shocked that the bone had grown and to a thickness over the protective screen and he was also shocked and that he had to scrape back the bone to insert the replacements. The dentist observes an unusual amount of bone growth for a 58-year-old man after a procedure. See the image bone growth thickness.
BLOOD LOSS FROM SURGERY CASE REPORT
1.21. Patient with Surgery Abnormal Uterine Bleeding and Chronic Pelvic Pain.
L.C. is a 55-year-old white female that was diagnosed with abnormal uterine bleeding and chronic pelvic pain on March; 1993. On October 31, 2022 patient was preoperative diagnoses; abnormal uterine bleeding, uterine fibroids, bulk symptoms, low-grade squamous intraepihelial lesion, history of cesarean delivery, history laparotomy, history of subtotal colectomy, and pre-diabetes. Outside imagine revealed an enlarged uterine with multiple uterine fibroids. Management options to proceed with hysterectomy. Ovarian preservation versus oophorectomy was reviewed with the patient including risks, benefits, and alternatives. After verbalizing understanding, the patient desired oophorectomy. Patient started taking Golden Sunrise Nutraceutical Metabolic Treatment (Metabolic Treatment) to help with blood loss from surgery on October 19, 2022. Results: As a result of taking the Metabolic Treatment, on October 31, 2022 the surgeons and other medical professionals team were very impressed at the minimizing blood loss during operations due to the benefits for patient and the significant improvements in surgical outcomes. Surgical complete radical hysterectomy included debridement of excessive scar tissue patient had that took approximately 30-minutes longer than normal, but due to how well it was going, overall it only took 1½-hours instead of the projected time of 3-hours it normally takes. On October 31, 2022 blood loss from surgery estimated blood loss of less than 25-mL. Family patient they were in disbelief at how well patient was doing without any narcotic pain medications.
HYPERTENSION CASE REPORT
1.22. Patient with Hypertension, Cholesterol, Thyroid, and Pain.
M.C. is a 63-year-old Hispanic female that was diagnosed with hypertension September; 1992. Patient was physician referred to Golden Sunrise Nutraceutical (Golden Sunrise) after the physician could not improve the patients' condition as prescribed the prescription drugs lost efficacy to control high blood pressure. Patient started taking Golden Sunrise Nutraceutical Metabolic Treatment (Metabolic Treatment) on August 12, 2012. Results: After taking the Metabolic Treatment on August 17, 2012 blood pressure levels had decreased from 150/68-mmHg to 134/64-mmHg. On October 30, 2012 patient states that she does not take the prescription drugs. Patient states that since starting with Metabolic Treatment she takes prescription drugs by physician "AS NEED". Patient reports pain levels had reduced and feeling relaxed.
PARKINSON'S DISEASE CASE REPORT
1.23. Patient with Parkinson's Disease.
M.S. is a 62-year-old white male that was diagnosed by a neurologist with Parkinson's disease on January; 2018 and toxicity (heavy metal) tested was high in mercury, lead, and cadmium on May; 2018. Patient immune system was obviously weakened and was prescribed the prescription drugs. Since patient had not experienced any improvement from the prescription medications. Patient felt worse with the prescription drugs, he discontinued using it because didn't help at all and causing side-effects. Patient states the side-effects from prescription drugs swelling in the lower extremities, lower leg, feet swelled severely, and the left foot. Patient started taking Golden Sunrise Nutraceutical Metabolic Treatment (Metabolic Treatment) on May 06, 2018. Results: After taking the Metabolic Treatment, patient tremors were gone, posture improved from being stooped over, walking was easier smoother, patient was able to bicycle, and use weights. Patient had done heavy metal testing with another care provider before using Metabolic Treatment and patient reported that the levels DROPPED. Patient would notice some tremoring return, but only mildly at times, and especially when experience with stressed. The last contact with the patient on October 15, 2020, he was still doing great with no rigidity and rare tremoring. Patient is extremely happy with his much improved quality-of-life since the prescription drugs gave no benefit and only miserable side-effects. Patient states "I have experienced success with the Metabolic Treatment, my immune system is strengthened as I have had no illness since the pneumonia, and valley fever in Year-2017. Physically, I feel great and exercise daily utilizing weights, bands, tubing, walking, biking, and flexibility training. Tremors are infrequent and my energy level is high."
SCHIZOAFFECTIVE CASE REPORT
1.24. Patient with Schizoaffcetive Disorder
S.R. is a 40-year-old white male that was diagnosed with schizoaffective disorder on Septemebr; 1996. Patient experiences psychotic symptoms, symptoms of depression, and panic attacks. Patient has been in treatment with psychiatrists for 22-years and has a significant history of mental health issues, he had been hospitalized at a local psychiatric hospital for hallucinations. The patient was taking 8-prescription-drugs and 5-antipsychotics. Patient has a history of abusing marijuana, crank, acid, and mushrooms, between the ages of 17-year-old and 21-year-old. Patient stopped using substances when the hallucinations started. The patient had many hallucinations that had led to an unstable lifestyle and a possible danger to himself and others. Patient started taking Golden Sunrise Nutraceutical Metabolic Treatment (Metabolic Treatment) on July 07, 2016. Results: After 3-weeks of Metabolic Treatment, patient stated “my brain can’t keep up with my mind”, the patient noticed something taking place, he felt a warm feeling then noticed his mind to have a sense of clarity. The doctor and mother of the patient noticed the subject to be much calmer, and also, a reduction in anxiety was also observed. Patient reported that his brain was now aware of how his body was feeling, he felt that he had more energy, he was thinking clearer, he reported that his thoughts did not race, and he is able to keep up with his thoughts. After the patient continued to take Metabolic Treatment the patient was able remove 3-antipsychotics prescription drugs, and continued to improve. Over the next 2-months prescription drugs were decreased on November; 2016 he was taking 1-prescription-drug at bedtime, and 1-prescription-drug in the morning. Patient psychotic symptoms have not returned and his energy level focus and concentration continue to improve. Plans are to continue reducing his neuroleptic medication as tolerated. The patient says he has no more hallucinations and can focus his thoughts to be more productive. Both the doctor and mother have had similar observations and wish to continue with Metabolic Treatment.
FRAGILE X SYNDROME CASE REPORT
1.25. Patient with Fragile X Syndrome
J.W. is an 9-year-old white male that was diagnosed with fragile X syndrome on Year-2007. Because of the family history of fragile X syndrome, patient was diagnosed as having fragile X syndrome through amniocentesis and the diagnosis was then confirmed through genetic study through the Mind Health Center. This patient was born blue at birth and needed intubation and he did not walk until he was 22-month-old. Patient had trouble napping, sleeping, had difficulty with fine and gross motor coordination, presenting problem had to do with aggressiveness behavior, and Attention-Deficit/Hyperactivity Disorder (ADHD). This was towards other people as well as himself. Patient was taking 2-prescription-drugs. Patient started taking Golden Sunrise Nutraceutical Metabolic Treatment (Metabolic Treatment) on July 12, 2016. Results: After just 2½-weeks on the Metabolic Treatment, it was noted that patient ability to concentrate and focus had improved, a reduction in anxiety, verbal output had improved although he continued to be difficult to understand, and a behavioral improvement at school with interaction among other students. After 2-months of being on the Metabolic Treatment patient is less hyper, more verbal to the point of being able to be understood, patient is able to self-modulate his anger, and take time outs to avoid being destructive. The patient was noticeably improved as told by his mother and school teachers.
References
[1] Tieu, H. and Loeffler, M. (2022) Life Is Quantum Biology Effects Explained from the Schrodinger Equation, Serious or Life-threatening Conditions or Diseases, and COVID-19 Results. Journal of Biosciences and Medicines, DOI No.: 10.4236/jbm.2022.1010013.
[2] Tieu, H. and Loeffler, M. (2023) Tieu Equation Experimentation of Understanding by Energy Transfer Quantum Mechanics. Natural Science, DOI No.: 10.4236/ns.2023.153008.
[3] Huu S. Tieu & Martin F. Loeffler Volume 23 Issue 4 Version 1.0 Year 2023 Particle Becomes Energy = Energy Becomes Mass. ISSN No.: 2249-4626 & ISSN No.: 0975-5896 Global Journal of Science Frontier Research: A Physics and Space Science.
[4] Tieu, H. and Loeffler, M. (2023) Patient Quality-of-Life, Providers with Incentive Payments, Real-World Evidence, and Reducing Healthcare Costs through New Innovations. Health, DOI No.: 10.4236/health.2023.154022.
Copyright © 2018 - 2025 Golden Sunrise Nutraceutical - All Rights Reserved.